Department of Neurological Surgery, Thomas Jefferson University, Jefferson Hospital for Neuroscience, 909 Walnut Street 3rd Floor, Philadelphia, PA 19107, USA.
Neurosurg Clin N Am. 2009 Oct;20(4):419-29. doi: 10.1016/j.nec.2009.07.005.
Endovascular reperfusion therapy is evolving as a promising treatment in the setting of acute ischemic stroke. Careful patient selection and angiographic evaluation of the location and extent of occlusion are necessary for the successful management of stroke patients. Intra-arterial chemical thrombolysis, with such agents as alteplase and urokinase, has shown favorable results in the early management of cerebrovascular ischemia. Mechanical thrombolysis is becoming an adjunctive or alternative treatment therapy via novel clot dissolution and retrieval techniques. Existing and upcoming trials are investigating the safety and efficacy of neuroendovascular therapy while attempting to expand its indications in acute ischemic stroke.
血管内再灌注治疗在急性缺血性脑卒中的治疗中不断发展,成为一种有前途的治疗方法。为了成功管理脑卒中患者,需要对患者进行仔细的选择,并对闭塞的位置和程度进行血管造影评估。动脉内化学溶栓治疗,如使用阿替普酶和尿激酶等药物,已在早期管理脑血管缺血方面显示出良好的效果。机械溶栓治疗正在通过新型血栓溶解和提取技术成为一种辅助或替代治疗方法。现有的和即将进行的试验正在研究神经血管内治疗的安全性和有效性,同时试图扩大其在急性缺血性脑卒中的适应证。